LabCorp launches new COVID-19 clinical trial site to connect patients with U.S. research trials

Streamlining recruitment into studies to speed research

Labcorp accelerates adoption of decentralized clinical trials, expands technology ecosystem through alliance with Medable

BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.

Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US

LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June

LabCorp launches return to work services for employers

Employers Now Have Access to LabCorp’s High-Quality COVID-19 Testing Capabilities Including Its New Fingerstick Antibody Blood Test 

Labcorp significantly expands availability of its COVID-19 at-home collection test kit

Consumers Now Have Access to the At-Home Test Collection Kit Online with No Upfront Costs, In Addition to Healthcare Workers and First Responders